【摘要】 目的 基于网络药理学与分子对接技术研究舒泌通胶囊（SMT）治疗前列腺炎的作用机制。方法 通过TCMSP和BATMAN-TCM数据库筛选出SMT的活性成分和靶蛋白，利用DisGeNET、Genecards和CTD数据库查找疾病相关靶点。获得交集靶点后构建蛋白质互作网络（PPI），针对PPI网络进行网络拓扑分析及靶点筛选从而获得SMT治疗前列腺炎的关键靶点网络，并对关键靶点进行GO和KEGG富集分析。采用分子对接计算验证网络中的关键成分和关键靶点。结果 共获得SMT的81个活性成分和883个作用靶标，前列腺炎靶点922个和交集靶点183个。经分析，得到SMT治疗前列腺炎的30个核心靶点，包括CTNNB1、JUN、CASP3、HIF1A等，主要通过高级糖基化终末产物-受体信号通路、白细胞介素-17、肿瘤坏死因子等信号通路治疗前列腺炎。分子对接结果显示大多数分子与目标蛋白质的结合能力较好，结合能均<-7 kcal/mol。结论 SMT中木犀草素、槲皮素、菊酮等活性成分作用于以CTNNB1、JUN、CASP3、HIF1A等为核心的靶点网络，通过白细胞介素-17和肿瘤坏死因子信号通路干预前列腺炎的发生，为SMT治疗前列腺炎的机制研究提供了相关理论基础。更多还原

【Abstract】 Objective To study the mechanism of Shubitong capsules(SMT) in the treatment of prostatitis based on network pharmacology and molecular docking. Methods The active components and target proteins of SMT were screened out through the TCMSP and BATMAN TCM databases, and disease-related targets were identified by using the DisGeNET, Genecards and CTD databases. After obtaining the intersection targets, a protein-protein interaction(PPI) network was constructed. Network topology analysis and target screening were conducted on the PPI network to obtain the key target network for SMT treatment of prostatitis, and GO and KEGG enrichment analyses were performed on the key targets. The key components and key targets in the network were verified by molecular docking calculations. Results A total of 81 active ingredients and 883 action targets of SMT were obtained, including 922 prostatitis targets and 183 intersection targets. After analysis, 30 core targets of SMT for the treatment of prostatitis were obtained, including CTNNB1, JUN, CASP3, and HIF1A. It mainly treats prostatitis through the Advanced Glycation End products-Receptor for AGE(AGE-RAGE) signaling pathway, interleukin-17(IL-17), tumor necrosis factor(TNF) and other signaling pathways. The results of molecular docking showed that the binding ability of most molecules to the target protein was good, and that the binding energies were all less than-7 kcal/mol. Conclusion The active ingredients in SMT, such as luteolin, quercetin, and chrysanthenone, act on the target network centered on CTNNB1, JUN, CASP3, and HIF1A, and intervene in the occurrence of prostatitis through IL-17 and TNF signaling pathways, providing a relevant theoretical basis for the mechanism research of SMT in the treatment of prostatitis.更多还原